U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 14-20, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 14-20, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 02/17/2021
Location: Virtual
Subject: Continued Pandemic Response and Emergency Use Authorizations
FDA Participant/Group: MELISSA ROBB; JULIA TIERNEY;
Non FDA Participant/Group: Marc Casper, Peter Shearstone (Thermo Fisher Scientific);

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 02/18/2021
Location: Virtual
Subject: COVID-19 Evidence Accelerator Therapeutics Lab Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 02/19/2021
Location: Virtual
Subject: Connected Health Initiative Meeting
FDA Participant/Group: ARUNAN SKANDARAJAH; LAURA ROE; ANINDITA SAHA;
Non FDA Participant/Group: Industry stakeholders

Official Name: Erika Anderson, Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/16/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: SHARON MAYL; ANDREW KENNEDY; SUSAN KELLY; CAITLIN BOON; LARRY MORRIS;
Non FDA Participant/Group: Carin Gerhardt, Helen Hartnett, John Hartnett (SVG Ventures, THRIVE);

Event Date: 02/17/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives and members of the National Association of State Departments of Agriculture

Event Date: 02/17/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; CAITLIN BOON;
Non FDA Participant/Group: Kyle Kinner, Sandra Eskin (The Pew Charitable Trusts);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top